CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 90 enrolled
Drug / intervention
Transcather Valve Implantationdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02119442
NCT02119442N/ACompleted
CompareCT.gov

Transcatheter Valve Implantation in Patients With Dysfunctional Left and Right Sided Heart Valves

University of California, Los Angeles·interventional·Posted Apr 21, 2014·Updated Apr 30, 2019

In Brief

A clinical study evaluating Transcather Valve Implantation for Eisenmenger Syndrome. Completed, enrolled 90 participants across 1 site.

Detailed Summary

A growing body of data, suggests that transcatheter valves are effective when implanted in other locations (mitral, aortic, tricuspid) and in high pressure environments. The investigators plan to offer transcatheter valve implantation as an alternative to high risk surgery in patients who require revision of a stenotic or regurgitant valve in the non-pulmonary position (mitral, aortic, tricuspid). This therapy can provide an alternative to patients who may be considered high risk and may not be able to survive a surgical procedure.The use of the devices on this protocol are for medical treatment and are not part of a clinical trial.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsEisenmenger Syndrome
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
2014201520162017201820192020202120222023202420252026
First PostedApr 21, 2014
Enrollment StartAug 1, 2013
Primary CompletionFeb 1, 2018
TodayJul 2, 2026
Enrollment to primary: 4.5 yearsPosted 12.2 years ago

Interventions

Transcather Valve Implantationdevice

Transcather Valve Implantation